{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:15:10Z","timestamp":1761178510213,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.canrad.2016.07.089","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T12:47:54Z","timestamp":1473425274000},"page":"543-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radioth\u00e9rapie des lymphomes malins non hodgkiniens localis\u00e9s de type MALT (gastriques et de la r\u00e9gion orbitaire)"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8781-2540","authenticated-orcid":false,"given":"L.","family":"Qu\u00e9ro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruskon\u00e9-Fourmestraux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.canrad.2016.07.089_bib0005"},{"year":"2014","series-title":"Lymphoma: pathology, diagnosis, and treatment","author":"Marcus","key":"10.1016\/j.canrad.2016.07.089_bib0010"},{"key":"10.1016\/j.canrad.2016.07.089_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","article-title":"Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type","volume":"24","author":"Thieblemont","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jncimonographs\/lgu011","article-title":"Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Bracci","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.canrad.2016.07.089_bib0025","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108\u00a0patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158\u00a0patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2016.07.089_bib0035","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/annonc\/mds644","article-title":"Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database","volume":"24","author":"Olszewski","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420\u00a0patients in Japan","volume":"61","author":"Nakamura","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.canrad.2016.07.089_bib0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","article-title":"Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105\u00a0patients with localized gastric marginal zone B-cell lymphoma of MALT type","volume":"20","author":"Stathis","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0050","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.3748\/wjg.v19.i45.8181","article-title":"Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management","volume":"19","author":"Nakamura","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0055","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1136\/gutjnl-2014-307389","article-title":"Helicobacter pylori infection in gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma: a re-evaluation","volume":"63","author":"Sena Teixeira Mendes","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.canrad.2016.07.089_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","article-title":"Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review","volume":"47","author":"Zullo","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0070","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H.\u00a0pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canrad.2016.07.089_bib0075","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","article-title":"Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy","volume":"23","author":"Levy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0080","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskone-Fourmestraux","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.canrad.2016.07.089_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/mdp146","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Zucca","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19\u00a0Randomized Study","volume":"31","author":"Zucca","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annonc\/mdn668","article-title":"Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy","volume":"20","author":"Gobbi","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up","volume":"117","author":"Ruskone-Fourmestraux","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0115","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","article-title":"Long-term results of stomach-conserving therapy in gastric MALT lymphoma","volume":"87","author":"Vrieling","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis","volume":"27","author":"Zullo","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH727>3.0.CO;2-J","article-title":"Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa","volume":"192","author":"Du","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2559.1992.tb00912.x","article-title":"Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease","volume":"20","author":"Wotherspoon","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.canrad.2016.07.089_bib0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02468883","article-title":"The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification","volume":"11","author":"Kajitani","year":"1981","journal-title":"Jpn J Surg"},{"key":"10.1016\/j.canrad.2016.07.089_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prro.2012.05.004","article-title":"Four-dimensional versus 3-dimensional computed tomographic planning for gastric mucosa associated lymphoid tissue lymphoma","volume":"3","author":"Jang","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1269\/jrr.11127","article-title":"Usefulness of 4D-CT for radiation treatment planning of gastric MZBCL\/MALT","volume":"53","author":"Matoba","year":"2012","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2016.07.089_bib0155","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone","volume":"16","author":"Schechter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0160","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.10.025","article-title":"Radiation treatment planning techniques for lymphoma of the stomach","volume":"62","author":"Della Biancia","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0165","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0360-3016(01)02729-8","article-title":"Primary radiotherapy for localized orbital MALT lymphoma","volume":"52","author":"Le","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0175","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.canrad.2015.04.008","article-title":"Tumeurs malignes ophtalmologiques\u00a0: indications de la radioth\u00e9rapie et techniques","volume":"19","author":"Jardel","year":"2015","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.07.089_bib0180","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/1097-0142(19940501)73:9<2395::AID-CNCR2820730924>3.0.CO;2-V","article-title":"Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma","volume":"73","author":"Bairey","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.07.089_bib0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2016.07.089_bib0190","series-title":"Radiotherapy of intraocular and orbital tumors","first-page":"205","article-title":"Lymphoid tumors of the orbit","author":"Lambo","year":"1993"},{"key":"10.1016\/j.canrad.2016.07.089_bib0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(84)90051-8","article-title":"Lymphoreticular tumors of the orbit","volume":"10","author":"Fitzpatrick","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAP.0b013e3181e4abdb","article-title":"Ocular adnexal lymphomas: a review","volume":"17","author":"McKelvie","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/107327481602300208","article-title":"Extranodal marginal zone B-cell lymphoma of the ocular adnexa","volume":"23","author":"Johnson","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.canrad.2016.07.089_bib0210","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2016.07.089_bib0215","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajo.2005.03.060","article-title":"Periocular mucosa-associated lymphoid\/low grade lymphomas: treatment with antibiotics","volume":"140","author":"Abramson","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0220","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0225","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/cncr.22843","article-title":"Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics","volume":"110","author":"Husain","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.07.089_bib0230","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","article-title":"Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial","volume":"98","author":"Ferreri","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2016.07.089_bib0235","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0240","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/CAD.0b013e32830b58c4","article-title":"Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations?","volume":"19","author":"Decaudin","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canrad.2016.07.089_bib0245","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00002341-199903000-00012","article-title":"Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa","volume":"15","author":"Kennerdell","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.canrad.2016.07.089_bib0255","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3109\/10428194.2014.979415","article-title":"Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy","volume":"56","author":"Parikh","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.canrad.2016.07.089_bib0260","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50\u00a0patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.07.089_bib0265","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2005.03.005","article-title":"Radiation therapy for orbital lymphoma","volume":"63","author":"Zhou","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0270","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/cncr.11317","article-title":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy","volume":"97","author":"Wenzel","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.07.089_bib0275","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86\u00a0patients with 104\u00a0treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.089_bib0280","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2016.07.089_bib0285","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","article-title":"Anti-CD20\u00a0monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva","volume":"73","author":"Nuckel","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.canrad.2016.07.089_bib0290","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","article-title":"Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma","volume":"65","author":"Raderer","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.canrad.2016.07.089_bib0295","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1349-7006.2011.01976.x","article-title":"Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study","volume":"102","author":"Savino","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canrad.2016.07.089_bib0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.leukres.2004.05.011","article-title":"Rituximab in primary conjunctiva lymphoma","volume":"29","author":"Zinzani","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.canrad.2016.07.089_bib0305","first-page":"269","article-title":"Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?","volume":"9","author":"Restrepo","year":"1998","journal-title":"Crit Rev Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816303675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816303675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:28:44Z","timestamp":1761136124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321816303675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":61,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1278321816303675"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.07.089","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie des lymphomes malins non hodgkiniens localis\u00e9s de type MALT (gastriques et de la r\u00e9gion orbitaire)","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.07.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}